| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.29 | 9e-06 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.19 | 9e-06 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.27 | 2e-05 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.26 | 4e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.17 | 5e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.17 | 7e-05 |